SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016708
Filing Date
2023-05-12
Accepted
2023-05-12 16:51:08
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 774902
2 ex10-5.htm EX-10.5 250734
3 ex10-7.htm EX-10.7 49981
4 ex31-1.htm EX-31.1 11508
5 ex31-2.htm EX-31.2 11676
6 ex32-1.htm EX-32.1 7241
7 ex32-2.htm EX-32.2 7298
8 ex10-4_001.jpg GRAPHIC 4827
  Complete submission text file 0001493152-23-016708.txt   4016446

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20230331.xsd EX-101.SCH 32335
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogen-20230331_cal.xml EX-101.CAL 46371
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogen-20230331_def.xml EX-101.DEF 108625
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20230331_lab.xml EX-101.LAB 247222
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20230331_pre.xml EX-101.PRE 193006
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 393336
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 23916694
SIC: 2834 Pharmaceutical Preparations